Stock Rating Upgrade
The Value Trend Rating for Fresenius Medical Care AG &Co KG (NYSE: FMS) improved in recent days from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
Fresenius Medical Care AG &Co KG (NYSE: FMS) stock rose modestly by 0.8% on 11/22/24. The stock closed at $22.16. However, trading volume in this advance was below average at 69% of normal. The stock has performed in line with the market over the last nine months and has risen 3.9% during the last week.
Current PriceTarget Research Rating
Fresenius Medical Care AG &Co KG has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Fresenius Medical Care AG &Co KG has a very high Appreciation Score of 85 but a neutral Power Rating of 43, and the Positive Value Trend Rating results.
Be the first to comment